4.7 Article

Fibroblast Activation Protein and Glycolysis in Lymphoma Diagnosis: Comparison of 68Ga-FAPI PET/CT and 18F-FDG PET/CT

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Radiology, Nuclear Medicine & Medical Imaging

Detecting Fibroblast Activation Proteins in Lymphoma Using 68Ga-FAPI PET/CT

Xiao Jin et al.

Summary: This study aimed to profile FAPs in different subtypes of lymphomas and explore the potential utility of Ga-68-FAPI PET/CT in lymphomas. The results showed significantly elevated FAP uptake in Hodgkin lymphoma lesions and aggressive non-Hodgkin lymphoma lesions, while indolent NHL lesions showed weak FAP staining. Ga-68-FAPI imaging can be used to detect FAP expression in lymphoma lesions and may be an alternate method for characterizing lymphoma profiles.

JOURNAL OF NUCLEAR MEDICINE (2022)

Editorial Material Radiology, Nuclear Medicine & Medical Imaging

68Ga-NOTA-FAPI-04 PET/CT in a patient with primary gastric diffuse large B cell lymphoma: comparisons with [18F] FDG PET/CT

Guochang Wang et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2021)

Article Radiology, Nuclear Medicine & Medical Imaging

Improved cancer detection in Waldeyer's tonsillar ring by68Ga-FAPI PET/CT imaging

S. Serfling et al.

Summary: In cancer of unknown primary (CUP) patients, non-invasive imaging of fibroblast activation protein (FAP) expression by [Ga-68]FAPI PET/CT resulted in better visual detection of the malignant primary compared to [F-18]FDG imaging. However, the detection rate of lymph node metastases was lower with [Ga-68]FAPI PET/CT, possibly due to low FAP expression in small metastases.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2021)

Review Pharmacology & Pharmacy

Tumor microenvironment as a therapeutic target in cancer

Yi Xiao et al.

Summary: This article summarizes the current progress in targeting the tumor microenvironment in both drug development and clinical trials, emphasizing the challenges in intervening in the tumor microenvironment and discussing strategies to maximize therapeutic benefits. New technologies and approaches to better understand the tumor microenvironment are explored in this context.

PHARMACOLOGY & THERAPEUTICS (2021)

Article Radiology, Nuclear Medicine & Medical Imaging

Imaging the Cancer Immune Environment and Its Response to Pharmacologic Intervention, Part 1: The Role of F-18-FDG PET/CT

Amir Iravani et al.

JOURNAL OF NUCLEAR MEDICINE (2020)

Review Oncology

The Tumor Microenvironment of DLBCL in the Computational Era

Giuseppina Opinto et al.

FRONTIERS IN ONCOLOGY (2020)

Article Radiology, Nuclear Medicine & Medical Imaging

68Ga-FAPI PET/CT: Tracer Uptake in 28 Different Kinds of Cancer

Clemens Kratochwil et al.

JOURNAL OF NUCLEAR MEDICINE (2019)

Review Oncology

Targetting the Tumor Microenvironment of Leukemia and Lymphoma

Uta E. Hoepken et al.

TRENDS IN CANCER (2019)

Review Biochemistry & Molecular Biology

Tumor metabolism, cancer cell transporters, and microenvironmental resistance

Khalid O. Alfarouk

JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2016)

Review Oncology

The tumour microenvironment in B cell lymphomas

David W. Scott et al.

NATURE REVIEWS CANCER (2014)

Article Radiology, Nuclear Medicine & Medical Imaging

Glut1 and Glut3 expression in lymphoma and their association with tumor intensity on 18F-fluorodeoxyglucose positron emission tomography

Amir H. Khandani et al.

NUCLEAR MEDICINE COMMUNICATIONS (2009)